Congrats!!
QCC, NF et GHG mooning 
3 « J'aime »
Après plus de 16 mois dans le marché spéculatif du cannabis, je me dis mission accomplie, j’ai bien surfé la vague et je remercie les gens qui ont posté sur cette discussion pour alimenter les idées. QCC et GHG ont fait ma journée! Je vous souhaite une bonne année 2018 et beaucoup de gain en perspectives car ce n’est pas terminé! Santé et prospérité 
@ stockguru2k11: 2018 $UMB 
2 « J'aime »
GHG et NF avec presse que 100 % ont fait ma journée de mon côté. J’ai bien hate aussi de voir UMB reprendre!
3 « J'aime »
C’est un site que je suis depuis environ deux mois et j ai embarqué dans leur montée et je vous dit merci et vous souhaite une bonne année 2018 sur vos titres et la santé bien sûr 
1 « J'aime »
QCC rendu à 0.90$
3 « J'aime »
Vois tu encore une appréciation malgré la nouvelle de hier ?
Globe says Medreleaf CEO questions pot stock valuations
2018-01-04 07:45 ET - In the News
See In the News (C-LEAF) Medreleaf Corp
The Globe and Mail reports in its Thursday, Jan. 4, edition that soaring pot stock valuations are “outrageous.”
The Globe’s Tim Kiladze writes that is how he described weed equities in September. Mr. Kiladze says he is now the butt of endless jokes. He says, however, his take on valuations is even more apt now.
Medreleaf chief executive officer Neil Closner says: “What appears to be the case is that the market is valuing companies on total announced production capacity. Period. It doesn’t take into account that they may not be able to do it. There’s no execution risk being factored in.”
Mr. Kiladze says pot investors are viewing start-up cannabis companies, some with virtually no history or profit, as somehow infallible. He says the investors behind this hysteria are not necessarily rational buyers. He says psychological issues are likely skewing investors, too – whether they know it or not. He concedes it is excruciating to sit on the sidelines when you think your friends are getting rich without you.
Mr. Kiladze says it is hard to tell when the shakeout will come – or what will spark it. He says pot stocks could keep climbing from here, however, there will be a day when it all comes tumbling down.
UMB devient CANN, reprise des transactions demain, attachez vos tuques, le bid est déjà à 0.60$, il a du rattrapage à faire, mon prix cible est de 4$-5$ dans quelques mois
3 « J'aime »
pour l’instant la plupart des brokers ne voient pas CANN je crois. Je le vois maintenant. Bon call @stockguru2k11
1 « J'aime »
Ca ne fait que débuter pour CANN. Beaucoup de news à venir
$CANN est dispo sur BNCD même si UMB est encore comme $UMB.
Mes ordres d’achats sont placés (0.45, 0.5, 0.55, 0.6, 0.65). Fingers crossed!
0.65 exécuté
0.60 exécuté
2 « J'aime »
les prochaines semaines seront intéressantes avec l’approche de la license prévue pour la fin Février
1 « J'aime »
Finalement la consolidation du secteur fût de courte durée, la remontée est féroce. Une occasion comme celle-ci ( la légalisation du cannabis) arrive une fois dans la vie. C’est tout un nouveau secteur et nous sommes qu’aux balbutiements. J’espère que vous en profitez.
$CANN finit la journée à 0.72$ sur + de 15M en volume
5 « J'aime »
$CANN.c Halted at the request of the company pending news
Excellente nouvelle
Heritage Cannabis Holdings Signs Blockchain Letter of Intent
(via TheNewswire)
Vancouver, B.C. / TheNewswire / January 16, 2018 - HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or Company") is pleased to announce that it has signed a Letter of Intent (“LOI”) to acquire 20% of Stanley Park Digital Ltd (“SPD”), a blockchain developer based in Vancouver, BC for $500,000 in a combination of $250,000 cash and $250,000 shares, share price is based on the average of the closing price of the shares between January 10, 2018 and January 23, 2018.
Key terms of the LOI include the development of a Cannabis Supply Chain Management System which will be designed to track and document all aspects of production from ‘seed to sale’. By utilizing a blockchain technology base to underpin an internal management process, it will provide an avenue to guarantee quality and consistency of product, as well as allow traceablility and transparency for regulation oversight.
Additional terms include Heritage obtaining certain Rights of First Refusal on selected projects, and first priority on future funding rounds. Development on a proprietary cannabis supply chain management system is scheduled to begin late January.
“Becoming a licenced grower and producer of cannabis remains our top priority, however this is only one area we’re targeting in this industry.” says Jag Bal, CEO of Heritage “Whether it’s other late stage applicants, expansion properties, or ancillary products related to Cannabis, we are working hard at doing more to increase shareholder value. By working with the people at Stanley Park Digital to utilize a blockchain system, we are able to leverage cutting edge technology to further our own projects, as well as give Heritage the ability to benefit from all projects that are currently underway.”
It is the primary goal of Heritage to become a licenced cannabis grower, and in addition to source cannabis related product or service companies and help them reach their goals. As part of the strategic plan, the Company will look to acquire, in whole or in part, various cannabis related companies or projects. The Cannabis industry will be lucrative in many aspects, and we will focus on leveraging our expertise and contacts to forward projects deemed prospective.
Debra Senger, CEO of PhyeinMed states “Since the cannabis market is still very new, the options for technology to assist with supply chain and regulatory requirements are very limited. While this does not supersede the existing approved software solutions for seed to sale, and the standard that all cannabis producers in Canada need to utilize, we are encouraged that we can develop a parallel platform which can manage this whole process for us, and utilizing blockchain technology will better our ability to comply with any regulations which come about.”
About Heritage Cannabis Holdings Corporation
The Company is currently listed as a marijuana issuer having a 75% interest in PhyeinMed Inc, a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). The Company’s growth strategy involves many related aspects, including the growing, branding and selling of cannabis, and cannabis products, as well as assisting cannabis related products or services come to market.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORPORATION
“Jag Bal”
Jagdip Bal
President and CEO
1 « J'aime »
WOW! News de malade ! Canopy ferme un bought deal de 175M$ à 34.60$. Oui, vous avez bien lu 175M$ en bought deal !!! Faut croire que les gros fonds embarquent enfin. Le secteur va s’nflammer de nouveau après cette légère pause de 1 semaine.
1 « J'aime »
Canopy Growth Corporation Announces $175 Million Bought Deal Financing
SMITHS FALLS, ONTARIO–(Marketwired - Jan. 17, 2018) -
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
Canopy Growth Corporation (TSX:WEED) (“Canopy Growth” or the “Corporation”) announced today that it has entered into an agreement with a syndicate of underwriters co-led by GMP Securities L.P. (“GMP”) and BMO Capital Markets as joint bookrunners (“BMO” and together with GMP, the “Co-Lead Underwriters” and collectively with the syndicate, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, 5,060,000 common shares (the “Common Shares”) of the Corporation at a price of $34.60 per Common Share (the “Offering Price”) for aggregate gross proceeds to Canopy Growth of $175,076,000 (the “Offering”).
The Corporation has agreed to grant the Underwriters an over-allotment option to purchase up to an additional 759,000 Common Shares at the Offering Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering.
The Common Shares will be offered by way of a short form prospectus to be filed in all provinces of Canada (except Quebec). The Company intends to use the net proceeds from the Offering for capital expenditures for capacity expansion, working capital, and general corporate requirements. The Offering is expected to close on February 7, 2018 and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the Toronto Stock Exchange and the applicable securities regulatory authorities.
The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.
Here’s to Future Growth.
$CANN.c techniquement semble vouloir breakout ici. Mon target est 2$ d’ici la mi-Mars
2 « J'aime »